相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pro-apoptotic action of stilbene-induced COX-2 in cancer cells Convergence with the anti-apoptotic effect of thyroid hormone
Hung-Yun Lin et al.
CELL CYCLE (2009)
Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Merce Pallas et al.
CURRENT NEUROVASCULAR RESEARCH (2009)
Sumoylation of Transcription Factor Tec1 Regulates Signaling of Mitogen-Activated Protein Kinase Pathways in Yeast
Yuqi Wang et al.
PLOS ONE (2009)
The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production
Mandar Dave et al.
ARTHRITIS AND RHEUMATISM (2008)
MAPK-induced Ser(727) phosphorylation promotes SUMOylation of STAT1
Sari Vanhatupa et al.
BIOCHEMICAL JOURNAL (2008)
Resveratrol - A multitargeted agent for age-associated chronic diseases
Kuzhuvelil B. Harikumar et al.
CELL CYCLE (2008)
Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions
Andrea Jurisicova et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Resveratrol causes COX-2-and p53-dependent apoptosis in head and neck squamous cell cancer cells
Hung-Yun Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
Connie P. Matthews et al.
CANCER RESEARCH (2007)
Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells
Heng-Yuan Tang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Integrin αVβ3 contains a receptor site for resveratrol
Hung-Yun Lin et al.
FASEB JOURNAL (2006)
Sumoylation of p45/NF-E2:: Nuclear positioning and transcriptional activation of the mammalian β-like globin gene locus
YC Shyu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Nitric oxide induces apoptosis via AP-1-driven upregulation of COX-2 in rat pheochromocytoma cells
MH Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Role of the protein kinase C-←Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning
YT Xuan et al.
CIRCULATION (2005)
Death squads enlisted by the tumour suppressor p53
E Michalak et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis
CA Corcoran et al.
ONCOGENE (2005)
Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer
M Yao et al.
BRITISH JOURNAL OF CANCER (2004)
Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells
S Zhang et al.
BRITISH JOURNAL OF CANCER (2004)
Dysregulated post-transcriptional control of COX-2 gene expression in cancer
DA Dixon
CURRENT PHARMACEUTICAL DESIGN (2004)
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells
N Hendrickx et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1
A Chauchereau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells
AR Munkarah et al.
GYNECOLOGIC ONCOLOGY (2003)
Differential regulation of cyclooxygenase-2 expression by phytosphingosine derivatives, NAPS and TAPS, and its role in the NAPS or TAPS-mediated apoptosis
HJ Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality
C Ruegg et al.
ANNALS OF MEDICINE (2003)
p53-mediated induction of Cox-2 counteracts p53-or genotoxic stress-induced apoptosis
JA Han et al.
EMBO JOURNAL (2002)
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol
ZG Li et al.
CARCINOGENESIS (2002)
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation
Y Le Drean et al.
ENDOCRINOLOGY (2002)
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
HY Lin et al.
JOURNAL OF UROLOGY (2002)
Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1
G Zahner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism
A Shih et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen
JG King et al.
ONCOGENE (2001)
Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells
YS Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
P Campomenosi et al.
ONCOGENE (2001)
MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells
TX Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Minireview -: Biological effects of resveratrol
L Frémont
LIFE SCIENCES (2000)
分享论文
